Crinetics Pharmaceuticals, Inc. (CRNX)
36.80
-0.29
(-0.78%)
USD |
NASDAQ |
May 22, 16:00
36.79
-0.01
(-0.03%)
After-Hours: 20:00
Crinetics Pharmaceuticals Cash from Investing (Quarterly) : -252.36M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amneal Pharmaceuticals, Inc. | -21.71M |
| Aquestive Therapeutics, Inc. | -0.052M |
| Merck & Co., Inc. | -10.21B |
| Nektar Therapeutics | -350.79M |
| Prestige Consumer Healthcare, Inc. | -3.414M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -124.70M |
| Cash from Financing (Quarterly) | 389.88M |
| Free Cash Flow | -419.52M |
| Free Cash Flow Per Share (Quarterly) | -1.206 |
| Free Cash Flow to Equity (Quarterly) | -124.84M |
| Free Cash Flow to Firm (Quarterly) | -125.52M |
| Free Cash Flow Yield | -11.78% |